[科学出版物中的利益冲突和可能的后果:以良性前列腺增生 (BPH) 为例的批判性分析]
Jonas Herrmann1,2, Christopher Netsch3
1Urologisches Laserzentrum Berlin, Vivantes Auguste-Viktoria-Klinikum, Rubenstraße 125, 12157, Berlin, Deutschland. Jonas.herrmann@vivantes.de.
Urologie (Heidelberg, Germany)
|March 10, 2025
概括
产业对内分泌学的资助,特别是对良性前列腺增生症 (BPH) 治疗的资助,可以通过研究设计和财务关系来影响科学证据. 保持科学独立需要平衡创新与无偏见的研究和以患者为中心的结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医疗技术 医疗技术 医学技术
- 科学完整性 科学完整性
背景情况:
- 对于医学进步而言,内分泌学方面的技术创新至关重要.
- 医疗专业人员与行业之间的合作存在潜在的利益冲突.
- 良性前列腺增生症 (BPH) 治疗是这些动态的一个关键案例研究.
研究的目的:
- 检查行业影响内分泌学科学证据的机制.
- 分析行业影响对BPH治疗证据质量的影响.
- 在行业伙伴关系中提出维持科学独立性的战略.
主要方法:
- 分析行业影响机制:选择性研究设计,赞助活动,财务关系.
- 对Aquablation,Rezum和UroLift® BPH治疗方法的案例研究评估.
- 评估临床研究中的方法特征和终点选择.
主要成果:
- 产业通过偏见的研究设计和选择性报告来影响科学证据.
- 在BPH治疗研究中的方法选择可能会影响证据的质量.
- 工业和医疗专业人员之间的财务关系代表着一个重要的利益冲突.
结论:
- 在内分泌学中,平衡技术创新与科学诚信至关重要.
- 加强独立研究资金对于无偏见的证据生成至关重要.
- 纳入患者的偏好和确保长期的结果跟踪对于强大的研究至关重要.
相关概念视频
Disorders of the Male Reproductive System
285
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
285
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
122
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
122
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
124
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
124


